Richard A. Schnizer

Array ( [id] => 9916697 [patent_doc_number] => 20150071902 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2015-03-12 [patent_title] => 'Extended DNA-Sensing GRNAS' [patent_app_type] => utility [patent_app_number] => 14/326361 [patent_app_country] => US [patent_app_date] => 2014-07-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 12 [patent_no_of_words] => 16603 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14326361 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10967002 [patent_doc_number] => 20140370034 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2014-12-18 [patent_title] => 'SDF-1 Binding Nucleic Acids and the Use Thereof' [patent_app_type] => utility [patent_app_number] => 14/324199 [patent_app_country] => US [patent_app_date] => 2014-07-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 50 [patent_figures_cnt] => 50 [patent_no_of_words] => 53345 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14324199 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 11499503 [patent_doc_number] => 20170073689 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2017-03-16 [patent_title] => 'MODULATORS OF GROWTH HORMONE RECEPTOR' [patent_app_type] => utility [patent_app_number] => 14/902446 [patent_app_country] => US [patent_app_date] => 2014-07-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 69668 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14902446 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10974290 [patent_doc_number] => 20140377324 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2014-12-25 [patent_title] => 'Pharmaceutical Composition Comprising miRNA-100 And Its Use In The Modulation of Blood Vessel Growth and Endothelial Inflammation' [patent_app_type] => utility [patent_app_number] => 14/320324 [patent_app_country] => US [patent_app_date] => 2014-06-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 16 [patent_figures_cnt] => 16 [patent_no_of_words] => 9691 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14320324 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 11836738 [patent_doc_number] => 20170218454 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2017-08-03 [patent_title] => 'Products and Methods Relating to Micro RNAS and Cancer' [patent_app_type] => utility [patent_app_number] => 14/901707 [patent_app_country] => US [patent_app_date] => 2014-06-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 26 [patent_figures_cnt] => 26 [patent_no_of_words] => 58335 [patent_no_of_claims] => 27 [patent_no_of_ind_claims] => 15 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14901707 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 11888229 [patent_doc_number] => 09758782 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2017-09-12 [patent_title] => 'Inhibition of microRNA for treatment of sepsis' [patent_app_type] => utility [patent_app_number] => 14/901549 [patent_app_country] => US [patent_app_date] => 2014-06-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 32 [patent_no_of_words] => 17796 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 35 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14901549 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10975493 [patent_doc_number] => 20140378528 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2014-12-25 [patent_title] => 'BIOMARKERS OF MIR-34 ACTIVITY' [patent_app_type] => utility [patent_app_number] => 14/313471 [patent_app_country] => US [patent_app_date] => 2014-06-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 24 [patent_figures_cnt] => 24 [patent_no_of_words] => 12291 [patent_no_of_claims] => 35 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14313471 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10797781 [patent_doc_number] => 20160143938 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2016-05-26 [patent_title] => 'Methods and compositions for modulating cancer stem cells' [patent_app_type] => utility [patent_app_number] => 14/899549 [patent_app_country] => US [patent_app_date] => 2014-06-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 43557 [patent_no_of_claims] => 98 [patent_no_of_ind_claims] => 28 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14899549 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10799458 [patent_doc_number] => 20160145615 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2016-05-26 [patent_title] => 'AGONISTS OF DDAH1 FOR TREATING ENDOTHELIAL DYSFUNCTION' [patent_app_type] => utility [patent_app_number] => 14/899247 [patent_app_country] => US [patent_app_date] => 2014-06-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 14 [patent_figures_cnt] => 14 [patent_no_of_words] => 15659 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 9 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14899247 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10784426 [patent_doc_number] => 20160130583 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2016-05-12 [patent_title] => 'DOUBLE-STRANDED ANTISENSE NUCLEIC ACID WITH EXON-SKIPPING EFFECT' [patent_app_type] => utility [patent_app_number] => 14/898630 [patent_app_country] => US [patent_app_date] => 2014-06-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 11 [patent_no_of_words] => 15410 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14898630 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10784399 [patent_doc_number] => 20160130555 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2016-05-12 [patent_title] => 'METHODS FOR MATURING CARDIOMYOCYTES AND USES THEREOF' [patent_app_type] => utility [patent_app_number] => 14/897403 [patent_app_country] => US [patent_app_date] => 2014-06-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 43 [patent_figures_cnt] => 43 [patent_no_of_words] => 28990 [patent_no_of_claims] => 39 [patent_no_of_ind_claims] => 22 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14897403 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 11011293 [patent_doc_number] => 20160208246 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2016-07-21 [patent_title] => 'COMPOSITIONS AND METHODS FOR TREATING A HEMATOLOGICAL MALIGNANCY ASSOCIATED WITH AN ALTERED RUNX1 ACTIVITY OR EXPRESSION' [patent_app_type] => utility [patent_app_number] => 14/897281 [patent_app_country] => US [patent_app_date] => 2014-06-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 25 [patent_figures_cnt] => 25 [patent_no_of_words] => 51650 [patent_no_of_claims] => 29 [patent_no_of_ind_claims] => 10 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14897281 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10960465 [patent_doc_number] => 20140363493 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2014-12-11 [patent_title] => 'LIPID NANOPARTICLES FOR TARGETED siRNA DELIVERY' [patent_app_type] => utility [patent_app_number] => 14/299194 [patent_app_country] => US [patent_app_date] => 2014-06-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 15 [patent_figures_cnt] => 15 [patent_no_of_words] => 7229 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14299194 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 11025432 [patent_doc_number] => 20160222387 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2016-08-04 [patent_title] => 'ANTI-TUMOR THERAPY' [patent_app_type] => utility [patent_app_number] => 14/893690 [patent_app_country] => US [patent_app_date] => 2014-05-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 18 [patent_figures_cnt] => 18 [patent_no_of_words] => 15756 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14893690 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9799534 [patent_doc_number] => 20150011478 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2015-01-08 [patent_title] => 'CMV GENE PRODUCTS PROMOTE CANCER STEM CELL GROWTH' [patent_app_type] => utility [patent_app_number] => 14/270094 [patent_app_country] => US [patent_app_date] => 2014-05-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 26 [patent_figures_cnt] => 26 [patent_no_of_words] => 23024 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14270094 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10515990 [patent_doc_number] => 09243026 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2016-01-26 [patent_title] => 'ENA nucleic acid pharmaceuticals capable of modifying splicing of mRNA precursors' [patent_app_type] => utility [patent_app_number] => 14/258663 [patent_app_country] => US [patent_app_date] => 2014-04-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 22 [patent_figures_cnt] => 22 [patent_no_of_words] => 85988 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 55 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14258663 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10226313 [patent_doc_number] => 20150111306 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2015-04-23 [patent_title] => 'HEMOGLOBIN A1c-SPECIFIC APTAMER, HEMOGLOBIN-SPECIFIC APTAMER, AND APPLICATIONS THEREOF' [patent_app_type] => utility [patent_app_number] => 14/225081 [patent_app_country] => US [patent_app_date] => 2014-03-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 5344 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14225081 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9772432 [patent_doc_number] => 20140296095 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2014-10-02 [patent_title] => 'Spatially Selective Release of Aptamer-Captured Cells by Temperature Mediation' [patent_app_type] => utility [patent_app_number] => 14/223767 [patent_app_country] => US [patent_app_date] => 2014-03-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 20 [patent_figures_cnt] => 20 [patent_no_of_words] => 7840 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14223767 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9757448 [patent_doc_number] => 20140288150 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2014-09-25 [patent_title] => 'DENDRONIZED POLYMERS FOR NUCLEIC ACID DELIVERY' [patent_app_type] => utility [patent_app_number] => 14/221249 [patent_app_country] => US [patent_app_date] => 2014-03-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 17 [patent_figures_cnt] => 17 [patent_no_of_words] => 16801 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14221249 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 14454657 [patent_doc_number] => 10323281 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2019-06-18 [patent_title] => Kits and methods for evaluating, selecting and characterizing tissue culture models using micro-RNA profiles [patent_app_type] => utility [patent_app_number] => 14/777811 [patent_app_country] => US [patent_app_date] => 2014-03-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 22 [patent_figures_cnt] => 22 [patent_no_of_words] => 9347 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 366 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14777811 [rel_patent_id] =>[rel_patent_doc_number] =>)